Abstract
Movement disorder emergencies of the aerodigestive tract are dramatic and often life threatening. With appropriate, timely evaluation and intervention, most patients can be effectively managed and major morbidity avoided. This chapter provides a comprehensive review of both the causes and appropriate treatment of breathing disturbances secondary to primary disorders and iatrogenic causes, as well as swallowing emergencies. Additionally, basic physiology, anatomy, and various methods for assessment of the upper aerodigestive tract are provided for review. Specific disorders that are addressed include: spasmodic dysphonia, adductor laryngeal breathing dystonia, Shy–Drager abductor weakness, drug-induced tardive dystonia, oromandibulolingual dystonia, multiple system atrophy, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson’s disease, Huntington’s disease, and palatal myoclonus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brin MF, Fahn S, Blitzer A, Ramig LO, Stewart C. Movement disorders of the larynx. In: Blitzer A, Brin MF, Sasaki CT, Fahn S, Harris KS, editors. Neurologic disorders of the larynx. New York: Thieme Medical Publishers Inc.; 1992. p. 248–78.
Braun N, Abd A, Baer J, Blitzer A, Stewart C, Brin M. Dyspnea in dystonia; a functional evaluation. Chest. 1995;107:1309–16.
Marion MH, Klap P, Perrin A, Cohen M. Stridor and focal laryngeal dystonia. Lancet. 1992;339:815.
Grillone GA, Blitzer A, Brin MF, Annino Jr DJ, Saint-Hilaire MH. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A. Laryngoscope. 1994;104:30–2.
Lew MF, Shindo M, Moscowitz CB, Wilhemsen KC, Fahn S, Waters CH. Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome). Mov Disord. 1994;9:318–20.
Merlo IM, Occhini A, Pacchetti C, Alfonsi E. Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology. 2002;58:649–52.
Panegyres PK, Hillman D, Dunne JW. Laryngeal dystonia causing upper airway obstruction in progressive supranuclear palsy. J Clin Neurosci. 2007;14:380–1.
Smith RL, Brown DH. Shy-Drager syndrome: an otolaryngology perspective. J Otolaryngol. 2000;29:59–61.
Tousi B. Movement disorder emergencies in the elderly: recognizing and treating an often-iatrogenic problem. Cleve Clin J Med. 2008;75:449–57.
Deguchi K, Ikeda K, Goto R, et al. The close relationship between life-threatening breathing disorders and urine storage dysfunction in multiple system atrophy. J Neurol. 2010;257(8):1287–92.
Yoshihara T, Yamamura Y, Kaneko F, et al. Neuromuscular junctions of the posterior cricoarytenoid muscle in multiple system atrophy: a case study. Acta Otolaryngol Suppl. 2009;562:115–9.
Kuzniar TJ, Morgenthaler TI, Prakash UB, et al. Effects of continuous positive airway pressure on stridor in multiple system atrophy-sleep laryngoscopy. J Clin Sleep Med. 2009;15:65–7.
Suzuki M, Saigusa H, Shibasaki K, et al. Multiple system atrophy manifesting as complex sleep-disordered breathing. Auris Nasus Larynx. 2010;37:110–3.
Moreno-Lopez C, Santamaria J, Salamero M, et al. Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Arch Neurol. 2011;68:223–30.
Wirshing WC. Movement disorders associated with neuroleptic treatment. J Clin Psychiatry. 2001;21:15–8.
Glazer WM. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality. J Clin Psychiatry. 2000;61:16–21.
Marsden CD, Jenner P. The pathophysiology of extrapyramidal side effects of neuroleptic drugs. Psychol Med. 1980;10:55–72.
Rowley H, Lynch T, Keogh I, Russell J. Tardive dystonia of the larynx in a quadriplegic patient: an unusual cause of stridor. J Laryngol Otol. 2001;115:918–9.
Fines RE, Brady Jr WJ, Martin ML. Acute laryngeal dystonia related to neuroleptic agents. Am J Emerg Med. 1999;17:319–20.
Miller AJ. Neurophysiological basis of swallowing. Dysphagia. 1986;1:91–100.
Logemann J. Manual for the videoflouroscopic study of swallowing. Austin, TX: Proed; 1993.
Bastien RW. Videoendoscopic evaluation of patients with dysphagia: an adjunct to the modified barium swallow. Otolaryngol Head Neck Surg. 1991;104:339–50.
Aviv JE, Kin T, Sacco RL, et al. FEESST: a new bedside endoscopic test of the motor and sensory components of swallowing. Ann Otol Rhinol Laryngol. 1998;107:378–87.
Aviv JE. Prospective randomized outcome study of endoscopy versus modified barium swallow in patients with dysphagia. Laryngoscope. 2000;110:563–74.
Setzen M, Cohen MA, Mattucci KF, Perlman PW, Ditkoff MK. Laryngopharyngeal sensory deficits as a predictor of aspiration. Otolaryngol Head Neck Surg. 2001;124:622–4.
McConnel FMS. Analysis of pressure generation and bolus transit during pharyngeal swallowing. Laryngoscope. 1988;98:71–8.
McConnel FMS, Cevenko D, Mendelsohn MS. Manofluorographic analysis of swallowing. Otolaryngol Clin North Am. 1988;21:625–35.
Flint PW, Purcell LL, Cummings CW. Pathophysiology and indications for medialization thyroplasty in patients with dysphagia and aspiration. Otolaryngol Head Neck Surg. 1997;16:349–54.
Strome SE. Aspiration. In: Gates G, editor. Current therapy in otolaryngology head and neck surgery. 6th ed. St. Louis: Mosby; 1998. p. 453–6.
Wisdom G, Krespi YP, Blitzer A. Surgical therapy for chronic aspiration. Oper Tech Otolaryngol Head Neck Surg. 1997;8:199–208.
Brin MF, Blitzer A, Herman S, Stewart C. Oromandibular dystonia: treatment of 96 patients with botulinum toxin type A. In: Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker, Inc.; 1994. p. 429–35.
Brin MF, Danisi F, Blitzer A. Blepharospasm, oromandibular dystonia, Meige’s syndrome and hemifacial spasm. In: Moore P, editor. Handbook of botulinum toxin treatment. 2nd ed. London: Blackwell Science; 2003. p. 119–41.
Parkes D, Schachter M. Meige, Breughel, or Blake. Neurology. 1981;31:498.
Gowers WR. Manual of diseases of the nervous system. 3rd ed. London: Churchill; 1899. p. 200.
Meige H. Les convusions de la face: une forme clinique de la convulsions faciales, bilateral et mediane. Rev Neurol (Paris). 1910;21:437–43.
Marsden CD. Blepharospasm-oromandibular dystonia syndrome (Brueghal’s syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry. 1976;39:1204–9.
Thompson PD, Obeso JA, Delgato G, Gallego J, Marsden CD. Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry. 1986;49:651–6.
Jankovic J. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy. Adv Neurol. 1988;50:583–91.
Tolosa E, Marti MJ. Blepharospasm-oromandibular dystonia (Meige’s syndrome): clinical aspects. Adv Neurol. 1988;49:73–84.
Tolosa E, Kulisevsky J, Fahn S. Meige syndrome: primary and secondary forms. Adv Neurol. 1988;50:509–15.
Tolosa ES. Clinical features of Meige’s disease (idiopathic orofacial dystonia). A report of 17 cases. Arch Neurol. 1981;38:147–51.
Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol. 1983;13:402–11.
Berardelli A, Rothwell J, Day B, Marsden CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain. 1985;108:593–608.
Nutt JG, Hammerstad JP. Blepharospasm and oromandibualr dystonia (Meige’s syndrome) in sisters. Ann Neurol. 1981;9:189–91.
Marsden CD. Problems of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life. Adv Neurol. 1976;14:259–76.
Defazio G, Lamberti P, Lepore V, Livrea P, Ferrari E. Facial dystonia: clinical features, prognosis, and pharmacology in 31 patients. Ital J Neurol Sci. 1989;10:553–60.
Jordan DR, Patrinely JR, Anderson RL, Thiese SM. Essential blepharospasm and related dystonias. Surv Ophthalmol. 1989;34:123–32.
Kirton CA, Riopelle RJ. Meige syndrome secondary to basal ganglia injury: a potential cause of acute respiratory distress. Can J Neurol Sci. 2001;28:167–73.
Brin MF. Advances in dystonia: genetics and treatment with botulinum toxin. In: Smith B, Adelman G, editors. Neuroscience year, supplement to the encyclopedia of neuroscience. Boston: Birkhauser; 1992. p. 56–8.
Blitzer A, Brin MF, Greene PE, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol. 1989;98:93–7.
Greene P, Shale H, Fahn S. Analysis of open-label trial in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord. 1988;3:46–60.
Gollomp SM, Fahn S, Burke RE, Reches A, Ilson J. Therapeutic trials in Meige syndrome. Adv Neurol. 1983;37:207–13.
Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. 1999;53:2102–7.
Charous SJ, Comella CL, Fan W. Jaw-opening dystonia: quality of life after botulinum toxin injections. Ear Nose Throat J. 2011;90:E9.
Yoshida K, Kaji R, Shibasaki H, Iizuka T. Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology. Int J Oral Maxillofac Surg. 2002;31:499–505.
Adler CH, Factor SA, Brin MF, Sethi KD. Secondary nonresponsiveness to botulinum toxin A in patients with oromandibular dystonia. Mov Disord. 2002;17:158–61.
Brin MF, Blitzer A, Greene PE, Fahn S. Botulinum toxin therapy for the treatment of oromandibulolingual dystonia (OMD). Neurology. 1988;38 Suppl 1:294.
Blitzer A, Brin MF, Fahn S. Botulinum toxin injections for lingual dystonia. Laryngoscope. 1991;101:799.
Charles PD, Davis TL, Shannon KM, Hook MA, Warner JS. Tongue protrusion dystonia: treatment with botulinum toxin. South Med J. 1997;90:522–5.
Lyons MK, Birch BD, Hillman RA, et al. Long-term follow-up of deep brain stimulation for Meige syndrome. Neurosurg Focus. 2010;29(2):E5.
Higo R, Tayama N, Watanabe T, et al. Vocal fold motion impairment in patients with multiple system atrophy: evaluation of its relationship with swallowing function. J Neurol Neurosurg Psychiatry. 2003;74:982–4.
Abraham SS, Yun PT. Laryngopharyngeal dysmotility in multiple sclerosis. Dysphagia. 2002;16:69–74.
Prosiegel M, Schelling A, Wagner-Sonntag E. Dysphagia and multiple sclerosis. Int MS J. 2004;11(1):22–31.
Eretkin C, Aydogdu I, Yuceyar N, et al. Pathophysiological mechanisms of oropharyngeal dysphagia in amyotrophic lateral sclerosis. Brain. 2000;123:125–40.
Eretkin C, Tarlaci S, Aydogdu I, et al. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson’s disease. Mov Disord. 2002;17(5):942–9.
Lever TE, Simon E, Cox KT, et al. A mouse model of pharyngeal dysphagia in amyotrophic lateral sclerosis. Dysphagia. 2010;25:112–26.
Spataro R, Ficano L, Piccoli F, La Bella V. Percutaneous endoscopic gastrostomy in amyothrophic lateral sclerosis: effect on survival. J Neurol Sci. 2011;15:44–8.
Potulska A, Friedman A, Krolicki L, et al. Swallowing disorders in Parkinson’s disease. Parkinsonism Relat Disord. 2003;9:349–53.
Cloud LJ, Greene JG. Gastrointestinal features of Parkinson’s disease. Curr Neurol Neurosci Rep. 2011;11(4):379–84.
Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17:10–5.
Fuh JL, Lee RC, Wang SJ, et al. Swallowing difficulty in Parkinson’s disease. Clin Neurol Neurosurg. 1997;99:106–12.
Edwards LL, Quigley EM, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology. 1992;42:726–32.
Sung HY, Kim JS, Lee KS, et al. The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson’s disease. Mov Disord. 2010;25:2361–8.
Menezes C, Melo A. Does levodopa improve swallowing dysfunction in Parkinson’s disease patients? J Clin Pharm Ther. 2009;34:673–6.
Troche MS, Okun MS, Rosenbek JC, et al. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology. 2010;75:1912–9.
Heemskerk AW, Roos RA. Dysphagia in Huntington’s disease: a review. Dysphagia. 2011;26:62–6.
Dubinsky RM. No going home for hospitalized Huntington’s disease patients. Mov Disord. 2005;20:1316–22.
Kagel MC, Leopold NA. Dysphagia in Huntington’s disease: a 16-year retrospective. Dysphagia. 1992;7:106–14.
Hamakawa S, Koda C, Umeno H, et al. Oropharyngeal dysphagia in a case of Huntington’s disease. Auris Nasus Larynx. 2004;31:171–6.
Pappert E, Goetz C. Myoclonus. In: Kurlan R, editor. Treatment of movement disorders. Philadelphia: JB Lippincott; 1995. p. 247–336.
Rivest J. Myoclonus. Can J Neurol Sci. 2003;30:S53–8.
Drysdale AJ, Ansell J, Adeley J. Palato-pharyngo-laryngeal myoclonus: an unusual cause of dysphagia and dysarthria. J Laryngol Otol. 1993;107:746–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Childs, L., Rickert, S., Bentsianov, B., Chitkara, A., Cultrara, A., Blitzer, A. (2013). Movement Disorder Emergencies of the Upper Aerodigestive Tract. In: Frucht, S. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-835-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-60761-835-5_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-834-8
Online ISBN: 978-1-60761-835-5
eBook Packages: MedicineMedicine (R0)